Related by context. Frequent words. (Click for all words.) 81 sBLA 75 Biologics License Application BLA 75 Biologics License Application 72 Marketing Authorization Application 71 Marketing Authorization Application MAA 70 sNDA 66 Complete Response 66 Orphan Drug status 64 Act PDUFA date 63 Fast Track Designation 63 Pivotal Phase III 63 Priority Review 62 Clolar 62 Investigational Device Exemption 62 Jevtana 62 Complete Response letter 62 New Drug Application 61 BENLYSTA 61 BLA submission 61 Orphan Drug designation 60 European Medicines Evaluation 60 Nexavar ® 60 registrational 60 SEROQUEL XR 60 REVLIMID R 60 lymphoma CTCL 59 cutaneous T cell 59 Fast Track designation 59 Marketing Authorization 59 taliglucerase alfa 59 PREOS 59 orphan medicinal product 59 alvimopan 58 Cimzia ® 58 NDA submission 58 Torisel 58 NUVIGIL 58 clofarabine 58 Research CDER 58 prGCD 57 Phenoptin 57 ADVEXIN 57 Pivotal Trial 57 ATryn R 57 Cladribine Tablets 57 Cimzia R 57 orphan designation 57 TORISEL 57 Investigational Device Exemption IDE 57 Rhucin ® 57 methylnaltrexone 57 bazedoxifene 57 Icatibant 57 BEMA Fentanyl 57 Restanza 56 Completes Enrollment 56 Acetavance 56 Pivotal Phase 56 Marqibo 56 pseudobulbar affect PBA 56 eltrombopag 56 Phase III Trial 56 Board DSMB 56 ridaforolimus 56 ponatinib 56 Cinryze TM 56 romiplostim 56 fidaxomicin 56 StaphVAX 56 vandetanib 56 Approvable Letter 56 Orphan Medicinal Product 56 NOXAFIL 56 Safe GRAS 56 NASDAQ CRXL 56 Nasdaq VRTX 55 OTCQX RHHBY 55 pediatric exclusivity 55 rNAPc2 55 Drug Application 55 HCV protease inhibitor 55 Pharmion Corporation 55 Phase IIb clinical 55 PROMACTA 55 MOZOBIL 55 FUSILEV 55 ThermoDox ® 55 Relistor 55 Orphan Drug Designation 55 FavId 55 INDs 55 Promacta 55 OFIRMEV 55 Azedra 55 Advexin 55 Swissmedic 55 Ventavis 55 Ceplene 55 SILENOR TM 55 Full Prescribing Information 55 Avastin bevacizumab